Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Futu Holdings Ltd (FUTU) vs Intuitive Surgical, Inc. (ISRG) Price & Performance

Futu Holdings LtdTrade
Intuitive Surgical, Inc.Trade

Price performance (Past 24H)

Key statistics

Futu Holdings Ltd vs Intuitive Surgical, Inc. — how do they compare? Futu Holdings Ltd trades at $105.31 (market cap $15.24B), while Intuitive Surgical, Inc. trades at $400.35 (market cap $138.97B). The key difference: Intuitive Surgical, Inc. is far larger — about 9.1× Futu Holdings Ltd's market cap, and Futu Holdings Ltd pays a 2.39% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals.

FUTUISRG
Market Cap
$15.24B$138.97B
Sector
FinancialsHealth
52-Week High
$199.04$592.85
52-Week Low
$89.76$332.02
Enterprise Value
$15.09B$133.76B
Dividend Yield
2.39%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Futu Holdings Ltd

Futu Holdings Limited (FUTU) trades at $109.02, up 4.31% today, with a bullish technical signal from moving averages and strong support at $106. The company reported robust 2025 revenue of $22.85 billion and net income of $11.34 billion, with a high net margin of 49.62%. Valuation ratios appear reasonable, with a P/E of 12.07 and P/S of 5.05. However, recent earnings misses in Q1 2026 and a securities class action lawsuit deadline on August 25, 2026, introduce near-term uncertainty.

The outlook for FUTU is mixed: strong profitability and analyst buy ratings (58% consensus) support upside, but legal risks and earnings volatility pose challenges. Investors should weigh solid fundamentals against regulatory and litigation headwinds, with technical levels suggesting $111 as immediate resistance.

Intuitive Surgical, Inc.

Intuitive Surgical (ISRG) trades at $378.81, up 1.36% with strong earnings momentum after beating Q2 2026 EPS estimates. The stock shows bullish technical signals despite premium valuations (P/E 43.44, P/S 12.35), supported by robust revenue growth reaching $10.06B in 2025 and expanding profit margins of 28.45%. Recent news highlights da Vinci 5 adoption driving procedure growth beyond urology.

Outlook remains positive with 68% analyst buy ratings and $519.05 price target suggesting 37% upside. Key risks include competitive pressure from Medtronic/J&J robots and potential U.S. procedure softness. The combination of durable demand and innovation pipeline supports long-term growth potential for MedTech investors.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Futu Holdings Ltd

Futu Holdings Ltd is an online broker providing one-stop online investing services. The company provides its services through its digital platform Futu NiuNiu, which includes market data, trading service, and news feed of Hong Kong, Mainland China, Singapore, and United States equity markets. It generates its revenue in the form of brokerage commission and handling charge services.

Read more on FUTU

About Intuitive Surgical, Inc.

Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.

Read more on ISRG